Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for design drugs
Most Correlated Studies
- Hepatocytes treated with four designer derivatives of piperazine
- Neural 3D tissue constructs from H1 ESC-derived precursor cells treated with neurotoxic chemicals
- Trophoblast stem cell gene expression during epithelial-mesenchymal transition
- ESC-derived stage 1 and stage 2 endoderm from SOX17+ precursors
- CD4+ Foxp3+ T reg cells derived from naive T cells by TGF-beta or harmine treatments
Most Relevant Literature
- Harnessing machine learning potential for personalised drug design and overcoming drug resistance.
- Diffusion Models in De Novo Drug Design.
- Pharmacophore-guided drug design using LdNMT as a model drug target for leishmaniasis.
- Rational Design of Drugs Targeting G-Protein-Coupled Receptors: Ligand Search and Screening.
- FragGrow: A Web Server for Structure-Based Drug Design by Fragment Growing within Constraints.
Most Relevant Clinical Trials
- Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)
- Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED)
- Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
- Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-elu…
- DESIGN OF A SCALE TO MEASURE COMPLIANCE WITH DRUG TREATMENT IN PATIENTS WITH ORAL CHEMOTHERAPY
